<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have investigated the anticancer effects of the dietary isothiocyanate <z:chebi fb="0" ids="47807">sulforaphane</z:chebi> (SFN) on <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), using primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells lines isolated from five Taiwanese <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients as the model for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>SFN-treated cells accumulated in metaphase (SFN 6.25 μM) and subG1 (SFN 12.5 and 25 μM) as determined by flow cytometry </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, treated cells showed nuclear apoptotic <z:mp ids='MP_0000002'>morphology</z:mp> that coincided with an activation of caspase-3, and loss of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane potential (ΔΨm) </plain></SENT>
<SENT sid="3" pm="."><plain>Incubations at higher SFN doses (12.5 and 25 μM) resulted in cleavage of procaspase-3 and elevated caspase-2, -3, -8, and -9 activity, suggesting that the induction of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and the <z:chebi fb="0" ids="47807">sulforaphane</z:chebi>-induced mitosis delay at the lower dose are independently regulated </plain></SENT>
<SENT sid="4" pm="."><plain>Daily SFN s.c. injections (400 micromol/kg/d for 3 weeks) in severe combined immunodeficient mice with primary human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (CP1 to CP5) s.c. <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> resulted in a decrease of mean <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> weight by 70% compared with vehicle-treated controls </plain></SENT>
<SENT sid="5" pm="."><plain>Our findings suggest that, in addition to the known effects on <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prevention, <z:chebi fb="0" ids="47807">sulforaphane</z:chebi> may have antitumor activity in established <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>